ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 31717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 31717; 2) Community: the network communities that were significantly associated with the response to NSC 31717; 3) Molecule: the relationships between components within communities and NSC 31717; 4) MDR: the compounds that were significantly associated with the NSC 31717.

NSC Compound Enrichment Correlation
NSC 600758 Null 0.0273071169565314 -0.13260663
NSC 610458 Camptothecin Derivative 0.0273071169565314 0.60613806
NSC 610459 Camptothecin Derivative 0.0273071169565314 0.65613132
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0273071169565314 0.11068565
NSC 622341 Null 0.0273071169565314 -0.22761
NSC 624474 Null 0.0273071169565314 0.062308223
NSC 625505 Null 0.0273071169565314 -0.18638337
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.0273071169565314 -0.20350642
NSC 637467 Disulfide, bis[2-amino-4-(4-methoxyphenyl)-1-methyl- 1H-imidazol-5-yl], dihydrochloride 0.0273071169565314 -0.14371359
NSC 639174 Camptothecin Derivative 0.0273071169565314 0.58644215
Total:119  Current:65    [First] [Prev] [Next] [Last]